ARISTOTLE ATLANTIC PARTNERS, LLC – Sage Therapeutics, Inc. Transaction History
ARISTOTLE ATLANTIC PARTNERS, LLC portfolio value:
$6.12M
portfolio value
ARISTOTLE ATLANTIC PARTNERS, LLC quarter portfolio value change:
+21.24%
quarter
Sage Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.88% | 1.36K shares | 1.11M | $39.16 | 156.47K |
| Q2 2022 | share | Increase | +1.98% | 3.01K shares | -24K | $32.3 | 155.11K |
| Q1 2022 | share | Increase | +0.80% | 1.20K shares | -1.38M | $33.1 | 152.10K |
| Q4 2021 | share | Decrease | -6.44% | -10.39K shares | -726K | $43.25 | 150.89K |
| Q3 2021 | share | Increase | +0.05% | 85 shares | -2.01M | $44.31 | 161.29K |
| Q2 2021 | share | Increase | +0.09% | 144 shares | -2.89M | $56.81 | 161.20K |
| Q1 2021 | share | Increase | +0.16% | 256 shares | -1.85M | $74.85 | 161.06K |
| Q4 2020 | share | Increase | +2.25% | 3.53K shares | 4.29M | $86.51 | 160.80K |
| Q3 2020 | share | Increase | +123.45% | 86.88K shares | 6.68M | $61.12 | 157.27K |
| Q2 2020 | share | Increase | +28.38% | 15.55K shares | 1.35M | $41.58 | 70.38K |
| Q1 2020 | share | Decrease | -18.92% | -12.78K shares | -3.30M | $28.72 | 54.82K |
| Q4 2019 | share | Increase | +382.61% | 53.60K shares | 2.91M | $72.19 | 67.61K |
| Q3 2019 | share | Increase | +0.77% | 107 shares | -579K | $140.29 | 14.01K |
| Q2 2019 | share | Decrease | -0.33% | -46 shares | 326K | $183.09 | 13.90K |
| Q1 2019 | share | Increase | +17.06% | 2.03K shares | 1.07M | $159.05 | 13.94K |
| Q4 2018 | share | Increase | +36.97% | 3.21K shares | 180K | $95.79 | 11.91K |
| Q3 2018 | share | 0.00% | 0 shares | -399K | $141.25 | 8.7K | |
| Q2 2018 | share | Increase | 0.00% | 8.7K shares | 1.36M | $156.53 | 8.7K |